Literature DB >> 22968459

IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells.

Solenne Vigne1, Gaby Palmer, Praxedis Martin, Céline Lamacchia, Deborah Strebel, Emiliana Rodriguez, Maria L Olleros, Dominique Vesin, Irene Garcia, Francesca Ronchi, Federica Sallusto, John E Sims, Cem Gabay.   

Abstract

The interleukin-1 (IL-1) superfamily of cytokines comprises a set of pivotal mediators of inflammation. Among them, the action of IL-36 cytokines in immune responses has remained elusive. In a recent study, we demonstrated a direct effect of IL-36 on immune cells. Here we show that, among T cells, the IL-36 receptor is predominantly expressed on naive CD4(+) T cells and that IL-36 cytokines act directly on naive T cells by enhancing both cell proliferation and IL-2 secretion. IL-36β acts in synergy with IL-12 to promote Th1 polarization and IL-36 signaling is also involved in mediating Th1 immune responses to Bacillus Calmette-Guerin infection in vivo. Our findings point toward a critical function of IL-36 in the priming of Th1 cell responses in vitro, and in adaptive immunity in a model of mycobacterial infection in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968459     DOI: 10.1182/blood-2012-06-439026

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  92 in total

1.  IL-36γ Promotes Killing of Mycobacterium tuberculosis by Macrophages via WNT5A-Induced Noncanonical WNT Signaling.

Authors:  Yuchi Gao; Qian Wen; Shengfeng Hu; Xinying Zhou; Wenjing Xiong; Xialin Du; Lijie Zhang; Yuling Fu; Jiahui Yang; Chaoying Zhou; Zelin Zhang; Yanfen Li; Honglin Liu; Yulan Huang; Li Ma
Journal:  J Immunol       Date:  2019-06-24       Impact factor: 5.422

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.

Authors:  F Ciccia; A Accardo-Palumbo; R Alessandro; C Alessandri; R Priori; G Guggino; S Raimondo; F Carubbi; G Valesini; R Giacomelli; A Rizzo; G Triolo
Journal:  Clin Exp Immunol       Date:  2015-06-03       Impact factor: 4.330

4.  Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.

Authors:  James DeVoti; Lynda Hatam; Alexandra Lucs; Ali Afzal; Allan Abramson; Bettie Steinberg; Vincent Bonagura
Journal:  Mol Med       Date:  2014-08-28       Impact factor: 6.354

5.  Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis.

Authors:  Mark Rochman; Jared Travers; Cora E Miracle; Mary C Bedard; Ting Wen; Nurit P Azouz; Julie M Caldwell; Kiran Kc; Joseph D Sherrill; Benjamin P Davis; Jeffrey K Rymer; Kenneth M Kaufman; Bruce J Aronow; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-01-17       Impact factor: 10.793

Review 6.  Interleukin 30 to Interleukin 40.

Authors:  Jovani Catalan-Dibene; Laura L McIntyre; Albert Zlotnik
Journal:  J Interferon Cytokine Res       Date:  2018-10       Impact factor: 2.607

7.  Inflammation: IL-36 has proinflammatory effects in skin but not in joints.

Authors:  Damien Dietrich; Cem Gabay
Journal:  Nat Rev Rheumatol       Date:  2014-09-09       Impact factor: 20.543

8.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.

Authors:  Xuefeng Wang; Xin Zhao; Chao Feng; Aliyah Weinstein; Rui Xia; Wen Wen; Quansheng Lv; Shuting Zuo; Peijun Tang; Xi Yang; Xiaojuan Chen; Hongrui Wang; Shayang Zang; Lindsay Stollings; Timothy L Denning; Jingting Jiang; Jie Fan; Guangbo Zhang; Xueguang Zhang; Yibei Zhu; Walter Storkus; Binfeng Lu
Journal:  Cancer Cell       Date:  2015-08-27       Impact factor: 31.743

10.  IL-36R signaling integrates innate and adaptive immune-mediated protection against enteropathogenic bacteria.

Authors:  Vu L Ngo; Hirohito Abo; Michal Kuczma; Edyta Szurek; Nora Moore; Oscar Medina-Contreras; Asma Nusrat; Didier Merlin; Andrew T Gewirtz; Leszek Ignatowicz; Timothy L Denning
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.